These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 23702822)
1. Does cancer start in the womb? altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors. Soto AM; Brisken C; Schaeberle C; Sonnenschein C J Mammary Gland Biol Neoplasia; 2013 Jun; 18(2):199-208. PubMed ID: 23702822 [TBL] [Abstract][Full Text] [Related]
2. Estrogens in the wrong place at the wrong time: Fetal BPA exposure and mammary cancer. Paulose T; Speroni L; Sonnenschein C; Soto AM Reprod Toxicol; 2015 Jul; 54():58-65. PubMed ID: 25277313 [TBL] [Abstract][Full Text] [Related]
3. In utero estrogenic endocrine disruption alters the stroma to increase extracellular matrix density and mammary gland stiffness. Wormsbaecher C; Hindman AR; Avendano A; Cortes-Medina M; Jones CE; Bushman A; Onua L; Kovalchin CE; Murphy AR; Helber HL; Shapiro A; Voytovitch K; Kuang X; Aguilar-Valenzuela R; Leight JL; Song JW; Burd CJ Breast Cancer Res; 2020 May; 22(1):41. PubMed ID: 32370801 [TBL] [Abstract][Full Text] [Related]
4. In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: an epigenetic mechanism linking endocrine disruptors to breast cancer. Doherty LF; Bromer JG; Zhou Y; Aldad TS; Taylor HS Horm Cancer; 2010 Jun; 1(3):146-55. PubMed ID: 21761357 [TBL] [Abstract][Full Text] [Related]
5. In Utero Exposure to Bisphenol a Promotes Mammary Tumor Risk in MMTV-Erbb2 Transgenic Mice Through the Induction of ER-erbB2 Crosstalk. Ma Z; Parris AB; Howard EW; Davis M; Cao X; Woods C; Yang X Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32353937 [TBL] [Abstract][Full Text] [Related]
6. Does breast cancer start in the womb? Soto AM; Vandenberg LN; Maffini MV; Sonnenschein C Basic Clin Pharmacol Toxicol; 2008 Feb; 102(2):125-33. PubMed ID: 18226065 [TBL] [Abstract][Full Text] [Related]
7. Evaluating chemical effects on mammary gland development: A critical need in disease prevention. Osborne G; Rudel R; Schwarzman M Reprod Toxicol; 2015 Jul; 54():148-55. PubMed ID: 25091782 [TBL] [Abstract][Full Text] [Related]
8. Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences. Fenton SE Endocrinology; 2006 Jun; 147(6 Suppl):S18-24. PubMed ID: 16690811 [TBL] [Abstract][Full Text] [Related]
9. Bisphenol A (BPA) Exposure In Utero Leads to Immunoregulatory Cytokine Dysregulation in the Mouse Mammary Gland: A Potential Mechanism Programming Breast Cancer Risk. Fischer C; Mamillapalli R; Goetz LG; Jorgenson E; Ilagan Y; Taylor HS Horm Cancer; 2016 Aug; 7(4):241-51. PubMed ID: 26911702 [TBL] [Abstract][Full Text] [Related]
10. Hormone receptor expression in aging mammary tissue and carcinoma from a rodent model after xenoestrogen disruption. Ruiz TFR; Colleta SJ; Zuccari DAPC; Vilamaior PSL; Leonel ECR; Taboga SR Life Sci; 2021 Nov; 285():120010. PubMed ID: 34606849 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of Prenatal Exposure to Bisphenol Analogues on Development and Long-Term Health of the Mammary Gland in Female Mice. Tucker DK; Hayes Bouknight S; Brar SS; Kissling GE; Fenton SE Environ Health Perspect; 2018 Aug; 126(8):087003. PubMed ID: 30102602 [TBL] [Abstract][Full Text] [Related]
12. Bisphenol S alters development of the male mouse mammary gland and sensitizes it to a peripubertal estrogen challenge. Kolla S; McSweeney DB; Pokharel A; Vandenberg LN Toxicology; 2019 Aug; 424():152234. PubMed ID: 31201878 [TBL] [Abstract][Full Text] [Related]
13. Mammary stroma in development and carcinogenesis. Sakakura T; Suzuki Y; Shiurba R J Mammary Gland Biol Neoplasia; 2013 Jun; 18(2):189-97. PubMed ID: 23604977 [TBL] [Abstract][Full Text] [Related]
14. The role of activin in mammary gland development and oncogenesis. Dunphy KA; Schneyer AL; Hagen MJ; Jerry DJ J Mammary Gland Biol Neoplasia; 2011 Jun; 16(2):117-26. PubMed ID: 21475961 [TBL] [Abstract][Full Text] [Related]
15. Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature. Moral R; Wang R; Russo IH; Lamartiniere CA; Pereira J; Russo J J Endocrinol; 2008 Jan; 196(1):101-12. PubMed ID: 18180321 [TBL] [Abstract][Full Text] [Related]
17. Mammary carcinoma in aged gerbil mothers after endocrine disruption in pregnancy and lactation. Ruiz TFR; Colleta SJ; Leonel ECR; Taboga SR Endocr Relat Cancer; 2021 Oct; 28(11):715-730. PubMed ID: 34486980 [TBL] [Abstract][Full Text] [Related]
18. [Role of prolactin in carcinogenesis and growth of mammary and breast neoplasms in animals and in man]. El'tsina NV Vopr Onkol; 1976; 22(12):81-91. PubMed ID: 798416 [TBL] [Abstract][Full Text] [Related]
19. Endocrine-active chemicals in mammary cancer causation and prevention. Jenkins S; Betancourt AM; Wang J; Lamartiniere CA J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):191-200. PubMed ID: 21729753 [TBL] [Abstract][Full Text] [Related]
20. Embryonic mammary gland development; a domain of fundamental research with high relevance for breast cancer research. Preface. Howard BA; Veltmaat JM J Mammary Gland Biol Neoplasia; 2013 Jun; 18(2):89-91. PubMed ID: 23686554 [No Abstract] [Full Text] [Related] [Next] [New Search]